TherapeuticsMD Inc (NASDAQ:TXMD)‘s stock had its “positive” rating restated by Jefferies Group LLC in a research note issued on Wednesday. They presently have a $18.00 price objective on the stock. Jefferies Group LLC’s price objective points to a potential upside of 218.58% from the company’s previous close. TXMD has been the subject of a number […]
